Janney Montgomery Scott’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,010
Closed -$405K 2787
2023
Q2
$405K Sell
16,010
-2,550
-14% -$64.5K ﹤0.01% 2023
2023
Q1
$598K Buy
+18,560
New +$598K ﹤0.01% 1611
2016
Q1
Sell
-8,425
Closed -$288K 1430
2015
Q4
$288K Sell
8,425
-3,895
-32% -$133K 0.01% 1074
2015
Q3
$367K Buy
12,320
+2,970
+32% +$88.5K 0.01% 964
2015
Q2
$299K Buy
+9,350
New +$299K 0.01% 1507
2014
Q3
Sell
-8,250
Closed -$281K 2332
2014
Q2
$281K Sell
8,250
-200
-2% -$6.8K 0.01% 1674
2014
Q1
$266K Buy
+8,450
New +$266K 0.01% 1539